TrialCancer science2021

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer.

Shin Takahashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.